![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
28
PharmaCompass offers a list of Cinnarizine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cinnarizine manufacturer or Cinnarizine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cinnarizine manufacturer or Cinnarizine supplier.
PharmaCompass also assists you with knowing the Cinnarizine API Price utilized in the formulation of products. Cinnarizine API Price is not always fixed or binding as the Cinnarizine Price is obtained through a variety of data sources. The Cinnarizine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-Cinnamyl-4-(diphenylmethyl)piperazine, including repackagers and relabelers. The FDA regulates 1-Cinnamyl-4-(diphenylmethyl)piperazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-Cinnamyl-4-(diphenylmethyl)piperazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine supplier is an individual or a company that provides 1-Cinnamyl-4-(diphenylmethyl)piperazine active pharmaceutical ingredient (API) or 1-Cinnamyl-4-(diphenylmethyl)piperazine finished formulations upon request. The 1-Cinnamyl-4-(diphenylmethyl)piperazine suppliers may include 1-Cinnamyl-4-(diphenylmethyl)piperazine API manufacturers, exporters, distributors and traders.
click here to find a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine DMF (Drug Master File) is a document detailing the whole manufacturing process of 1-Cinnamyl-4-(diphenylmethyl)piperazine active pharmaceutical ingredient (API) in detail. Different forms of 1-Cinnamyl-4-(diphenylmethyl)piperazine DMFs exist exist since differing nations have different regulations, such as 1-Cinnamyl-4-(diphenylmethyl)piperazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine DMF submitted to regulatory agencies in the US is known as a USDMF. 1-Cinnamyl-4-(diphenylmethyl)piperazine USDMF includes data on 1-Cinnamyl-4-(diphenylmethyl)piperazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1-Cinnamyl-4-(diphenylmethyl)piperazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine suppliers with USDMF on PharmaCompass.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP of the European Pharmacopoeia monograph is often referred to as a 1-Cinnamyl-4-(diphenylmethyl)piperazine Certificate of Suitability (COS). The purpose of a 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1-Cinnamyl-4-(diphenylmethyl)piperazine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1-Cinnamyl-4-(diphenylmethyl)piperazine to their clients by showing that a 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP has been issued for it. The manufacturer submits a 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP holder for the record. Additionally, the data presented in the 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1-Cinnamyl-4-(diphenylmethyl)piperazine DMF.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1-Cinnamyl-4-(diphenylmethyl)piperazine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine suppliers with CEP (COS) on PharmaCompass.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine written confirmation (1-Cinnamyl-4-(diphenylmethyl)piperazine WC) is an official document issued by a regulatory agency to a 1-Cinnamyl-4-(diphenylmethyl)piperazine manufacturer, verifying that the manufacturing facility of a 1-Cinnamyl-4-(diphenylmethyl)piperazine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1-Cinnamyl-4-(diphenylmethyl)piperazine APIs or 1-Cinnamyl-4-(diphenylmethyl)piperazine finished pharmaceutical products to another nation, regulatory agencies frequently require a 1-Cinnamyl-4-(diphenylmethyl)piperazine WC (written confirmation) as part of the regulatory process.
click here to find a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-Cinnamyl-4-(diphenylmethyl)piperazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1-Cinnamyl-4-(diphenylmethyl)piperazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1-Cinnamyl-4-(diphenylmethyl)piperazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1-Cinnamyl-4-(diphenylmethyl)piperazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-Cinnamyl-4-(diphenylmethyl)piperazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine suppliers with NDC on PharmaCompass.
1-Cinnamyl-4-(diphenylmethyl)piperazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1-Cinnamyl-4-(diphenylmethyl)piperazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1-Cinnamyl-4-(diphenylmethyl)piperazine GMP manufacturer or 1-Cinnamyl-4-(diphenylmethyl)piperazine GMP API supplier for your needs.
A 1-Cinnamyl-4-(diphenylmethyl)piperazine CoA (Certificate of Analysis) is a formal document that attests to 1-Cinnamyl-4-(diphenylmethyl)piperazine's compliance with 1-Cinnamyl-4-(diphenylmethyl)piperazine specifications and serves as a tool for batch-level quality control.
1-Cinnamyl-4-(diphenylmethyl)piperazine CoA mostly includes findings from lab analyses of a specific batch. For each 1-Cinnamyl-4-(diphenylmethyl)piperazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1-Cinnamyl-4-(diphenylmethyl)piperazine may be tested according to a variety of international standards, such as European Pharmacopoeia (1-Cinnamyl-4-(diphenylmethyl)piperazine EP), 1-Cinnamyl-4-(diphenylmethyl)piperazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1-Cinnamyl-4-(diphenylmethyl)piperazine USP).